Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca appoints new China head
AstraZeneca names exec to take on role of detained China head
AstraZeneca on Wednesday named Iskra Reic as its new international executive vice president (EVP), taking over from Leon Wang, who was detained by Chinese authorities in October. Reic will continue as head of AstraZeneca's vaccines and immune therapies business,
With AstraZeneca exec under investigation in China, company names Reic new international chief
With AstraZeneca’s former international chief, Leon Wang, under investigation in China, the company has promoted an AZ veteran to fill the post. | With AstraZeneca’s former international chief, Leon Wang,
AstraZeneca appoints new China head after long-standing executive detained
AstraZeneca has not given any details about the probe, which the Financial Times reported previously related to the alleged illegal importation of cancer drug Imjudo. The medicine has not been approved in China.
AstraZeneca names new international Executive VP to succeed Leon Wang
AstraZeneca said on Wednesday Iskra Reic will become its new international executive vice president succeeding Leon Wang, who was detained by Chinese authorities in October. The company said in late October its China operations were under the leadership of Michael Lai,
AstraZeneca Veteran Replaces Detained China Executive Leon Wang
AstraZeneca Plc has appointed Iskra Reic as executive vice-president of its international business, replacing Leon Wang who is under investigation by Chinese authorities.
3h
on MSN
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
FiercePharma
9h
AstraZeneca's Enhertu and Akeso's bispecifics win national coverage in China as CAR-T therapies miss out again
Enhertu won its initial China nod in early 2023 as a treatment for previously treated HER2-positive breast cancer and later ...
7h
AstraZeneca appoints Iskra Reic as Executive Vice President, International
AstraZeneca (AZN) announced the appointment of Iskra Reic as Executive Vice President, International with responsibility for overall strategy ...
15h
UK's FTSE 100 falls as AstraZeneca, BoE Governor's remarks weigh
The UK's benchmark FTSE 100 fell on Wednesday, ending a five-day winning streak, dragged by AstraZeneca's decline on target ...
Business Wire
2h
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AstraZeneca PLC (AZN) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on beh ...
STAT
2d
Despite probe, China reimbursing AstraZeneca drug
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
12h
AstraZeneca Strengthens Leadership with New EVP Appointment
AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At ...
1d
AstraZeneca PLC ADR rises Tuesday, outperforms market
The AstraZeneca PLC ADR AZN rallied 1.51% to $68.05 Tuesday, on what proved to be an all-around mixed trading session for the ...
6d
AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe
China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance amid an ...
2d
on MSN
Lightning Round: Take a pass on AstraZeneca, says Jim Cramer
Once a common sight among the trees, many of Japan's bear hunters are now older, and their numbers are dwindling. As the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
China
Leon Wang
Dow Jones Industrial Average
Iskra Reic
United Kingdom
Feedback